Log in to your Inderes Free account to see all free content on this page.
Zealand Pharma
315.00 DKK
+5.04 %
Less than 1K followers
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Zealand Pharma
P/E
Median 2019-2025
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 235.40 | 220.60 | 145.10 | 201.40 | 373.20 | 715.50 | 466.40 |
| Shares | 33.8 | 39.8 | 42.9 | 51.7 | 58.8 | 71.0 | 70.6 |
| Market cap | 7,957.0 | 8,779.7 | 6,220.3 | 10,412.8 | 21,925.9 | 50,817.6 | 32,931.2 |
| Enterprise value | 6,662.2 | 7,652.2 | 5,579.6 | 9,759.0 | 20,412.1 | 43,007.0 | - |
| EV/S | 161.2 | 21.7 | 19.1 | 93.8 | 59.5 | 686.0 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | 5.1 |
| P/B | 6.40 | 7.14 | 6.70 | 12.76 | 13.77 | 5.90 | 2.22 |
| P/S | 192.5 | 24.8 | 21.3 | 100.1 | 64.0 | 810.6 | 3.6 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 77.7 % | 69.8 % | 44.9 % | 53.0 % | 80.4 % | 90.6 % | 93.0 % |
| Gearing ratio | 6.9 % | 10.6 % | 84.9 % | 64.2 % | 7.5 % | 4.5 % | 2.7 % |
Login required
This content is only available for logged in users